Tue, November 29, 2011
Mon, November 28, 2011
Sun, November 27, 2011
Fri, November 25, 2011
Thu, November 24, 2011
Wed, November 23, 2011
[ Wed, Nov 23rd 2011 ] - Market Wire
00 a.m. EST
Tue, November 22, 2011
[ Tue, Nov 22nd 2011 ] - Market Wire
BD Board Increases Dividend
Mon, November 21, 2011
Sun, November 20, 2011
Fri, November 18, 2011
Thu, November 17, 2011
Wed, November 16, 2011
Tue, November 15, 2011

The Law Firm of Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of Pharmass


//health-fitness.news-articles.net/content/2011/ .. -of-fiduciary-duty-by-the-board-of-pharmass.html
Published in Health and Fitness on Monday, November 21st 2011 at 12:15 GMT by Market Wire   Print publication without navigation


The Law Firm of Levi & Korsinsky, LLP Announces Investigation into Possible... -- NEW YORK, Nov. 21, 2011 /PRNewswire/ --

The Law Firm of Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of Pharmasset, Inc. in Connection with the Sale of the Company to Gilead Sciences, Inc.

[ ]

 

NEW YORK, Nov. 21, 2011 /PRNewswire/ -- Levi & Korsinsky is investigating the Board of Directors of Pharmasset, Inc. ("Pharmasset" or the "Company") (NASDAQ: [ VRUS ]) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to Gilead Sciences, Inc. (NASDAQ: GILD).  Under the terms of the transaction, Pharmasset shareholders will receive $137 for each share of Pharmasset stock they own.  The transaction has a total approximate value of $11 billion.

Click here to learn how to join the action: [ http://www.zlk.com/pharmasset-vrus ], or call: 877-363-5972.

The investigation concerns whether the Pharmasset Board of Directors breached their fiduciary duties to Pharmasset stockholders by failing to adequately shop the Company before entering into this transaction and whether Gilead Sciences, Inc. is underpaying for Pharmasset shares, thus unlawfully harming Pharmasset stockholders. 

If you own common stock in Pharmasset and wish to obtain additional information, please contact Joseph E. Levi, Esq. either via email at [ jlevi@zlk.com ] or by telephone at (212) 363-7500, toll-free: (877) 363-5972, or [ http://www.zlk.com ].

Levi & Korsinsky is a national firm with offices in New York, California and Washington D.C.  The firm has extensive expertise in prosecuting investor securities litigation involving financial fraud and represents investors throughout the nation, concentrating its practice in securities and shareholder litigation.  The attorneys at Levi & Korsinsky have been appointed by numerous courts throughout the country to serve as lead counsel on behalf of shareholders in major litigations involving mergers and acquisitions.  For more information, please feel free to contact any of the attorneys listed below. Attorney advertising. Prior results do not guarantee similar outcomes.

CONTACT:
Levi & Korsinsky, LLP
Joseph Levi, Esq.
Eduard Korsinsky, Esq.
30 Broad Street - 15th Floor
New York, NY 10004
Tel: (212) 363-7500
Toll Free:  (877) 363-5972
Fax: (212) 363-7171
[ www.zlk.com ]

 

SOURCE Levi & Korsinsky

[ Back to top ]


Publication Contributing Sources